Schedule 13G ownership disclosure

NeuBase Therapeutics, Inc.

Security class unavailable · CUSIP: 64132K102

Event date: 2019-08-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
861,394
Percent of class
5.0500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001786406-19-000001
Form type
SC 13G
Filer
NeuBase Therapeutics, Inc.
CIK
CIK 1173281
Filed
Aug 27, 2019
Reporting period
Aug 27, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub